المصدر: MarketBeat
وكالة أنباء
الأسهم
أهمية متوسطة
Maravai LifeSciences Q2 Earnings Call Highlights
Maravai LifeSciences NASDAQ: MRVI reported second-quarter 2026 revenue growth and a sharp improvement in adjusted profitability, while maintaining its full-year revenue outlook and raising its adjusted EBITDA forecast.
الرموز ذات الصلة
1
M
MRVI
MRVI
المصدر: MarketBeat
زيارة المصدر